Generate a tailored SOP for Dr. Hans Schreiber. Improve your application with a focused, well-structured draft.
Hans Schreiber is a Professor at the University of Chicago, specializing in the study of fundamental mechanisms that govern the interaction between cancer cells and the immune system. His laboratory focuses on exploiting the presence of cancer-specific mutations and antigens in cancer cells to stimulate the immune system’s ability to destroy cancer cells disseminated throughout the body. Schreiber is particularly interested in understanding the mechanisms that allow immunogenic cancer cells to escape immune destruction and aims to develop new strategies based on novel therapeutic principles. His research integrates immunology, genetics, and biochemistry to uncover cancer-specific changes in malignant cells, identifying critical mechanisms that can be targeted immunologically. Schreiber earned his MD from the University of Freiburg in Germany and furthered his education with a PhD from the University of Chicago's Pritzker School of Medicine, where he also completed a residency in Anatomic Pathology.
Department of Philosophy